17-4899481-G-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_000080.4(CHRNE):c.1019C>G(p.Pro340Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,597,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P340L) has been classified as Likely benign.
Frequency
Consequence
NM_000080.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152134Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000769 AC: 17AN: 221008 AF XY: 0.0000752 show subpopulations
GnomAD4 exome AF: 0.0000692 AC: 100AN: 1445282Hom.: 0 Cov.: 34 AF XY: 0.0000697 AC XY: 50AN XY: 717190 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152134Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74304 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 4A Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 340 of the CHRNE protein (p.Pro340Arg). This variant is present in population databases (rs139922367, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 970144). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNE protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.1019C>G (p.P340R) alteration is located in exon 9 (coding exon 9) of the CHRNE gene. This alteration results from a C to G substitution at nucleotide position 1019, causing the proline (P) at amino acid position 340 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Congenital myasthenic syndrome Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at